Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Drug Resistance

  Free Subscription


Articles published in Int J Antimicrob Agents

Retrieve available abstracts of 256 articles:
HTML format
Text format



Single Articles


    August 2019
  1. MACHUCA I, Gutierrez-Gutierrez B, Rivera-Espinar F, Cano A, et al
    External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteremia cohort: The prognostic significance of colistin resistance.
    Int J Antimicrob Agents. 2019 Aug 1. pii: S0924-8579(19)30206.
    PubMed     Text format     Abstract available


    July 2019
  2. NIBBERING PH, Goblyos A, Adriaans AE, Cordfunke RA, et al
    Eradication of methicillin resistant S. aureus from human skin by the novel LL-37-derived peptide P10 in four pharmaceutical ointments.
    Int J Antimicrob Agents. 2019 Jul 26. pii: S0924-8579(19)30194.
    PubMed     Text format     Abstract available


  3. ZHANG L, Zhai W, Lin Q, Zhu X, et al
    Carbapenem-resistant Enterobacteriaceae in hematological patients: outcome of patients with Carbapenem-resistant Enterobacteriaceae infection and risk factors for progression to infection after rectal colonization.
    Int J Antimicrob Agents. 2019 Jul 3. pii: S0924-8579(19)30176.
    PubMed     Text format    


    June 2019
  4. LEE YL, Lu MC, Shao PL, Lu PL, et al
    Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria with an emphasis on carbapenems and colistin: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Int J Antimicrob Agents. 2019 Jun 13. pii: S0924-8579(19)30162.
    PubMed     Text format     Abstract available


  5. SMOKE S, Raja K, Narayanan N, Brunetti L, et al
    Selective Antibiotic Susceptibility Reporting and Broad-Spectrum Intravenous Antibiotic Use: a Multicenter Ecological Study.
    Int J Antimicrob Agents. 2019 Jun 13. pii: S0924-8579(19)30164.
    PubMed     Text format     Abstract available


  6. VAN DER WEIDE H, Vermeulen-de Jongh DMC, van der Meijden A, Boers SA, et al
    Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.
    Int J Antimicrob Agents. 2019 Jun 4. pii: S0924-8579(19)30136.
    PubMed     Text format     Abstract available


    May 2019
  7. HAFFLER ZJ, Kulengowski B, Ribes JA, Burgess DS, et al
    Evaluation of the BD Phoenix(TM) automated system for determining antimicrobial susceptibility against carbapenem-resistant Enterobacteriaceae compared to broth microdilution.
    Int J Antimicrob Agents. 2019 May 6. pii: S0924-8579(19)30109.
    PubMed     Text format     Abstract available


  8. THOMAS VM, Brown RM, Ashcraft DS, Pankey GA, et al
    Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2019;53:663-668.
    PubMed     Text format     Abstract available


  9. BARRAUD O, Laurent F, Dyon-Tafani V, Dupieux-Chabert C, et al
    Novel staphylococcal cassette chromosome composite island (SCC-CI) with a new subtype of SCCmecVI cassette found in ST5 methicillin-resistant Staphylococcus aureus in France.
    Int J Antimicrob Agents. 2019;53:694-697.
    PubMed     Text format     Abstract available


  10. BINDER J, Held J, Krappmann S
    Impairing fluoride export of Aspergillus fumigatus mitigates its voriconazole resistance.
    Int J Antimicrob Agents. 2019;53:689-693.
    PubMed     Text format     Abstract available


  11. POTRON A, Bour M, Triponney P, Muller J, et al
    Sequential emergence of colistin and rifampicin resistance in an OXA-72- producing outbreak strain of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2019;53:669-673.
    PubMed     Text format     Abstract available


  12. GOMEZ-JUNYENT J, Benavent E, Sierra Y, El Haj C, et al
    Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
    Int J Antimicrob Agents. 2019;53:612-619.
    PubMed     Text format     Abstract available


  13. CLARK ST, Sinha U, Zhang Y, Wang PW, et al
    Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with beta-lactams.
    Int J Antimicrob Agents. 2019;53:620-628.
    PubMed     Text format     Abstract available


    April 2019
  14. BHATTACHARJEE B, Bardhan T, Chakraborty M, Basu M, et al
    Resistance profiles and resistome mapping of multidrug resistant carbapenem-hydrolyzing Klebsiella pneumoniae strains isolated from the nares of preterm neonates.
    Int J Antimicrob Agents. 2019;53:535-537.
    PubMed     Text format    


  15. DOSSIM S, Bonnin RA, Salou M, Tanga K, et al
    Occurrence of carbapenemase-producing Enterobacteriaceae in Togo, West Africa.
    Int J Antimicrob Agents. 2019;53:530-532.
    PubMed     Text format    


  16. STERRANTINO G, Borghi V, Callegaro AP, Bruzzone B, et al
    Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors.
    Int J Antimicrob Agents. 2019;53:515-519.
    PubMed     Text format     Abstract available


  17. TRAGLIA GM, Place K, Dotto C, Fernandez JS, et al
    Interspecies DNA acquisition by a naturally competent Acinetobacter baumannii strain.
    Int J Antimicrob Agents. 2019;53:483-490.
    PubMed     Text format     Abstract available


  18. ZENG S, Meng X, Huang Q, Lei N, et al
    Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo.
    Int J Antimicrob Agents. 2019;53:362-369.
    PubMed     Text format     Abstract available


  19. LUNA BL, Garcia JA, Huang M, Ewing PJ, et al
    Identification and characterization of novel isothiazolones with potent bactericidal activity against multi-drug resistant Acinetobacter baumannii clinical isolates.
    Int J Antimicrob Agents. 2019;53:474-482.
    PubMed     Text format     Abstract available


  20. PIEWNGAM P, Quinones M, Thirakittiwatthana W, Yungyuen T, et al
    Composition of the intestinal microbiota in extended-spectrum beta-lactamase-producing Enterobacteriaceae carriers and non-carriers in Thailand.
    Int J Antimicrob Agents. 2019;53:435-441.
    PubMed     Text format     Abstract available


  21. ABBARA S, Pitsch A, Jochmans S, Hodjat K, et al
    Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Int J Antimicrob Agents. 2019;53:416-422.
    PubMed     Text format     Abstract available


  22. COUVE-DEACON E, Jove T, Afouda P, Barraud O, et al
    Class 1 integrons in Acinetobacter baumannii: a weak expression of gene cassettes to counterbalance the lack of LexA-driven integrase repression.
    Int J Antimicrob Agents. 2019;53:491-499.
    PubMed     Text format     Abstract available


  23. ZHANG X, Li Y, Wang W, Zhang J, et al
    Identification of an anti-Gram-negative bacteria agent disrupting the interaction between lipopolysaccharide transporters LptA and LptC.
    Int J Antimicrob Agents. 2019;53:442-448.
    PubMed     Text format     Abstract available


  24. SAIDANI N, Lagier JC, Cassir N, Million M, et al
    Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities.
    Int J Antimicrob Agents. 2019;53:355-361.
    PubMed     Text format     Abstract available


  25. VISCA P, Pisa F, Imperi F
    The antimetabolite 3-bromopyruvate selectively inhibits Staphylococcus aureus.
    Int J Antimicrob Agents. 2019;53:449-455.
    PubMed     Text format     Abstract available


  26. DURAND GA, Raoult D, Dubourg G
    Antibiotic discovery: history, methods and perspectives.
    Int J Antimicrob Agents. 2019;53:371-382.
    PubMed     Text format     Abstract available


  27. DE LA CALLE C, Rodriguez O, Morata L, Marco F, et al
    Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam.
    Int J Antimicrob Agents. 2019;53:520-524.
    PubMed     Text format     Abstract available


  28. KARLOWSKY JA, Hackel MA, Tsuji M, Yamano Y, et al
    In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015.
    Int J Antimicrob Agents. 2019;53:456-466.
    PubMed     Text format     Abstract available


  29. BASSETTI M, Castaldo N, Cattelan A, Mussini C, et al
    Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.
    Int J Antimicrob Agents. 2019;53:408-415.
    PubMed     Text format     Abstract available


    March 2019
  30. RAMSEY EG, Royer J, Bookstaver PB, Justo JA, et al
    Seasonal Variation in Antimicrobial Resistance Rates of Community-Acquired Escherichia coli Bloodstream Isolates.
    Int J Antimicrob Agents. 2019 Mar 15. pii: S0924-8579(19)30063.
    PubMed     Text format     Abstract available


  31. TEO JQ, Chang CW, Leck H, Tang CY, et al
    Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
    Int J Antimicrob Agents. 2019 Mar 14. pii: S0924-8579(19)30064.
    PubMed     Text format     Abstract available


  32. DAVIDO B, Batista R, Dinh A, de Truchis P, et al
    Fifty shades of graft: how to improve efficacy of Fecal Microbiota Transplantation (FMT) for decolonization of Antibiotic-Resistant Bacteria (ARB)?
    Int J Antimicrob Agents. 2019 Mar 14. pii: S0924-8579(19)30061.
    PubMed     Text format     Abstract available


  33. LEE T, Pang S, Abraham S, Coombs GW, et al
    Molecular characterization and evolution of the first outbreak of vancomycin resistant Enterococcus faecium in Western Australia.
    Int J Antimicrob Agents. 2019 Mar 6. pii: S0924-8579(19)30039.
    PubMed     Text format     Abstract available


  34. GOLDSTEIN E, MacFadden DR, Karaca Z, Steiner CA, et al
    Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.
    Int J Antimicrob Agents. 2019 Mar 6. pii: S0924-8579(19)30056.
    PubMed     Text format     Abstract available


  35. GAO Q, Wu S, Xu T, Zhao X, et al
    Emergence of Carbapenem Resistance in Bacteroides fragilis in China.
    Int J Antimicrob Agents. 2019 Mar 1. pii: S0924-8579(19)30047.
    PubMed     Text format     Abstract available


  36. VATS S, Shanker A
    Groups of coevolving positions provide drug resistance to Mycobacterium tuberculosis: A study using targets of first-line antituberculosis drugs.
    Int J Antimicrob Agents. 2019;53:197-202.
    PubMed     Text format     Abstract available


  37. NAGANO N, Koide S, Hayashi W, Taniguchi Y, et al
    Population-level transition of capsular polysaccharide types among sequence type 1 group B Streptococcus isolates with reduced penicillin susceptibility during a long-term hospital epidemic.
    Int J Antimicrob Agents. 2019;53:203-210.
    PubMed     Text format     Abstract available


  38. KLEIN S, Menz MD, Zanger P, Heeg K, et al
    Increase in the prevalence of Panton-Valentine leukocidin and clonal shift in community-onset methicillin-resistant Staphylococcus aureus causing skin and soft-tissue infections in the Rhine-Neckar Region, Germany, 2012-2016.
    Int J Antimicrob Agents. 2019;53:261-267.
    PubMed     Text format     Abstract available


  39. VAN DE PEPPEL RJ, van der Beek MT, Visser LG, de Boer MGJ, et al
    Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies.
    Int J Antimicrob Agents. 2019;53:284-293.
    PubMed     Text format     Abstract available


  40. PAPADOPOULOS A, Ribera A, Mavrogenis AF, Rodriguez-Pardo D, et al
    Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration.
    Int J Antimicrob Agents. 2019;53:294-301.
    PubMed     Text format     Abstract available


  41. JOUSSET AB, Bernabeu S, Bonnin RA, Creton E, et al
    Development and validation of a multiplex polymerase chain reaction assay for detection of the five families of plasmid-encoded colistin resistance.
    Int J Antimicrob Agents. 2019;53:302-309.
    PubMed     Text format     Abstract available


  42. KOULENTI D, Song A, Ellingboe A, Abdul-Aziz MH, et al
    Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
    Int J Antimicrob Agents. 2019;53:211-224.
    PubMed     Text format     Abstract available


  43. HEINRICHS MT, Drusano GL, Brown DL, Maynard MS, et al
    Dose optimization of moxifloxacin and linezolid against tuberculosis using mathematical modeling and simulation.
    Int J Antimicrob Agents. 2019;53:275-283.
    PubMed     Text format     Abstract available


  44. MENDONCA AA, de Morais MA Jr, Cabrera MZ
    Cysteine induces resistance of lactobacilli to erythromycin and azithromycin.
    Int J Antimicrob Agents. 2019;53:352-353.
    PubMed     Text format    


    February 2019
  45. LIU WL, Huang YT, Hsieh MH, Hii IM, et al
    Clinical characteristics of Candida tropicalis fungaemia with reduced triazole susceptibility in Taiwan: a multicentre study.
    Int J Antimicrob Agents. 2019;53:185-189.
    PubMed     Text format     Abstract available


  46. KAZMIERCZAK KM, Tsuji M, Wise MG, Hackel M, et al
    In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-beta-lactamase-producing isolates (SIDERO-W
    Int J Antimicrob Agents. 2019;53:177-184.
    PubMed     Text format     Abstract available


  47. POULAKOU G, Renieris G, Sabrakos L, Zarkotou O, et al
    Daptomycin as adjunctive treatment for experimental infection by Acinetobacter baumannii with resistance to colistin.
    Int J Antimicrob Agents. 2019;53:190-194.
    PubMed     Text format     Abstract available


  48. CHEN S, Liu H, Liang W, Hong L, et al
    Insertion sequences in the CRISPR-Cas system regulate horizontal antimicrobial resistance gene transfer in Shigella strains.
    Int J Antimicrob Agents. 2019;53:109-115.
    PubMed     Text format     Abstract available


  49. QUEK WM, Teng CB, Tan YZ, Chong K, et al
    Outcomes of Fosfomycin Use in Ceftriaxone-Resistant Enterobacteriaceae Urinary Tract Infection in the Elderly.
    Int J Antimicrob Agents. 2019;53:195-196.
    PubMed     Text format    


    January 2019
  50. CHIRAKUL S, Somprasong N, Norris MH, Wuthiekanun V, et al
    Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplification.
    Int J Antimicrob Agents. 2019 Jan 9. pii: S0924-8579(19)30003.
    PubMed     Text format     Abstract available


  51. FALAGAS ME, Athanasaki F, Voulgaris GL, Triarides NA, et al
    Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences.
    Int J Antimicrob Agents. 2019;53:22-28.
    PubMed     Text format     Abstract available


  52. DONG H, Xiang H, Mu D, Wang D, et al
    Exploiting a conjugative CRISPR/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli.
    Int J Antimicrob Agents. 2019;53:1-8.
    PubMed     Text format     Abstract available


  53. OTTO RG, van Gorp E, Kloezen W, Meletiadis J, et al
    An alternative strategy for combination therapy: Interactions between polymyxin B and non-antibiotics.
    Int J Antimicrob Agents. 2019;53:34-39.
    PubMed     Text format     Abstract available


  54. DIEZ-AGUILAR M, Ekkelenkamp M, Morosini MI, Merino I, et al
    Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients.
    Int J Antimicrob Agents. 2019;53:84-88.
    PubMed     Text format     Abstract available


  55. BERNARDINI A, Cuesta T, Tomas A, Bengoechea JA, et al
    The intrinsic resistome of Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2019;53:29-33.
    PubMed     Text format     Abstract available


  56. NGUYEN T, Akhavan S, Caby F, Bonyhay L, et al
    Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing.
    Int J Antimicrob Agents. 2019;53:80-83.
    PubMed     Text format     Abstract available


    December 2018
  57. OSTRER L, Khodursky RF, Johnson JR, Hiasa H, et al
    Analysis of Mutational Patterns in Quinolone Resistance-Determining Regions of GyrA and ParC of Clinical Isolates.
    Int J Antimicrob Agents. 2018 Dec 21. pii: S0924-8579(18)30366.
    PubMed     Text format     Abstract available


  58. AHMAD N, Ali SM, Khan AU
    Molecular characterization of novel sequence type of carbapenem-resistant NDM-1 producing Klebsiella pneumoniae in NICU of Indian Hospital.
    Int J Antimicrob Agents. 2018 Dec 19. pii: S0924-8579(18)30367.
    PubMed     Text format     Abstract available


  59. KHAWCHAROENPORN T, Chuncharunee A, Maluangnon C, Taweesakulvashra T, et al
    Active monotherapy and combination therapy for extensively drug-resistant Pseudomonas aeruginosa pneumonia.
    Int J Antimicrob Agents. 2018;52:828-834.
    PubMed     Text format     Abstract available


  60. ZINNER SH, Golikova MV, Strukova EN, Portnoy YA, et al
    Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin.
    Int J Antimicrob Agents. 2018;52:854-860.
    PubMed     Text format     Abstract available


  61. BENDER JK, Fleige C, Lange D, Klare I, et al
    Rapid emergence of highly variable and transferable oxazolidinone and phenicol resistance gene optrA in German Enterococcus spp. clinical isolates.
    Int J Antimicrob Agents. 2018;52:819-827.
    PubMed     Text format     Abstract available


  62. ZHANG JM, Wang Q, Han TY, Liu JH, et al
    Structure analysis of transposons carrying the aac(6')-aph(2'') gene in Enterococcus faecalis isolated in Beijing, China, and comparison of their transfer efficiency.
    Int J Antimicrob Agents. 2018;52:799-804.
    PubMed     Text format     Abstract available


  63. TANFOUS FB, Raddaoui A, Chebbi Y, Achour W, et al
    Epidemiology and molecular characterisation of colistin-resistant Klebsiella pneumoniae isolates from immunocompromised patients in Tunisia.
    Int J Antimicrob Agents. 2018;52:861-865.
    PubMed     Text format     Abstract available


  64. LOOSE M, Naber KG, Hu Y, Coates A, et al
    Serum bactericidal activity of colistin and azidothymidine combinations against mcr-1-positive colistin-resistant Escherichia coli.
    Int J Antimicrob Agents. 2018;52:783-789.
    PubMed     Text format     Abstract available


  65. KANZARI L, Ferjani S, Saidani M, Hamzaoui Z, et al
    First report of extensively-drug-resistant Proteus mirabilis isolate carrying plasmid-mediated blaNDM-1 in a Tunisian intensive care unit.
    Int J Antimicrob Agents. 2018;52:906-909.
    PubMed     Text format     Abstract available


  66. CHOUCHANI C, Rolain JM, Ghrairi T
    Recent advances in antimicrobial and bacterial resistance.
    Int J Antimicrob Agents. 2018;52:869-870.
    PubMed     Text format    


    November 2018
  67. LAZARO-PERONA F, Sotillo A, Troyano-Hernaez P, Gomez-Gil R, et al
    Genomic path to pandrug resistance in a clinical isolate of Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2018;52:713-718.
    PubMed     Text format     Abstract available


  68. MCKAMEY L, Venugopalan V, Cherabuddi K, Borgert S, et al
    Assessing antimicrobial stewardship initiatives: Clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms.
    Int J Antimicrob Agents. 2018;52:719-723.
    PubMed     Text format     Abstract available


  69. ABDOLRASOULI A, Scourfield A, Rhodes J, Shah A, et al
    High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre.
    Int J Antimicrob Agents. 2018;52:637-642.
    PubMed     Text format     Abstract available


  70. RUI Y, Lu W, Li S, Cheng C, et al
    Integrons and insertion sequence common region 1 (ISCR1) of carbapenem-non-susceptible Gram-negative bacilli in fecal specimens from 5000 patients in southern China.
    Int J Antimicrob Agents. 2018;52:571-576.
    PubMed     Text format     Abstract available


    October 2018
  71. KOSTYANEV T, Vilken T, Lammens C, Timbermont L, et al
    Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories part of the COMBACTE network: a COMBACTE LAB-Net survey.
    Int J Antimicrob Agents. 2018 Oct 31. pii: S0924-8579(18)30305.
    PubMed     Text format     Abstract available


  72. ZHONG H, Zhao XY, Zhang ZL, Gu ZC, et al
    Evaluation of the efficacy and safety of ceftazidime/avibactam in the treatment of Gram-negative bacterial infections: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;52:443-450.
    PubMed     Text format     Abstract available


  73. O'DONNELL JN, Rhodes NJ, Lopez J, Jett R, et al
    Carbapenems vs. alternative beta-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;52:451-458.
    PubMed     Text format     Abstract available


    September 2018
  74. OLIVEIRA FA, Zaccariotto TR, Piveta C, Hofling CC, et al
    MCR-1-positive colistin-resistant Escherichia coli in immunocompromised hospitalised patients.
    Int J Antimicrob Agents. 2018;52:438-440.
    PubMed     Text format    


  75. MCKINNON J, Roy Chowdhury P, Djordjevic SP
    Genomic analysis of multidrug-resistant Escherichia coli ST58 causing urosepsis.
    Int J Antimicrob Agents. 2018;52:430-435.
    PubMed     Text format     Abstract available


  76. TANSARLI GS, Papaparaskevas J, Balaska M, Samarkos M, et al
    Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis.
    Int J Antimicrob Agents. 2018;52:397-403.
    PubMed     Text format     Abstract available


  77. CHEN CM, Huang M, Wu HJ, Guo MK, et al
    Identification of CFE-2, a new plasmid-encoded AmpC beta-lactamase from a clinical isolate of Citrobacter freundii.
    Int J Antimicrob Agents. 2018;52:421-424.
    PubMed     Text format     Abstract available


  78. KIM SJ, Ko KS
    Diverse genetic alterations responsible for post-exposure colistin resistance in populations of the same strain of Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2018;52:425-429.
    PubMed     Text format     Abstract available


  79. MACAUX L, Ndoye O, Cordel H, Pomares TB, et al
    Extensively-drug-resistant bacteria carriers among overseas travellers: one-third had not been hospitalized previously.
    Int J Antimicrob Agents. 2018;52:385-389.
    PubMed     Text format     Abstract available


  80. DIEP JK, Covelli J, Sharma R, Ruszaj DM, et al
    Comparison of the composition and in vitro activity of polymyxin B products.
    Int J Antimicrob Agents. 2018;52:365-371.
    PubMed     Text format     Abstract available


  81. LIM SC, Androga GO, Knight DR, Moono P, et al
    Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.
    Int J Antimicrob Agents. 2018;52:411-415.
    PubMed     Text format     Abstract available


  82. COURTOIS N, Caspar Y, Maurin M
    Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
    Int J Antimicrob Agents. 2018;52:358-364.
    PubMed     Text format     Abstract available


  83. CROUGHS PD, Klaassen CHW, van Rosmalen J, Maghdid DM, et al
    Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
    Int J Antimicrob Agents. 2018;52:407-410.
    PubMed     Text format     Abstract available


  84. KHOO AL, Zhao YJ, Teng M, Ying D, et al
    Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
    Int J Antimicrob Agents. 2018;52:350-357.
    PubMed     Text format     Abstract available


  85. LOMOVSKAYA O, Sun D, Rubio-Aparicio D, Nelson KJ, et al
    Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2018;52:404-406.
    PubMed     Text format     Abstract available


  86. SCOTT AM, Beller E, Glasziou P, Clark J, et al
    Is antimicrobial administration to food animals a direct threat to human health? A rapid systematic review.
    Int J Antimicrob Agents. 2018;52:316-323.
    PubMed     Text format     Abstract available


  87. PROTONOTARIOU E, Poulou A, Politi L, Sgouropoulos I, et al
    Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece.
    Int J Antimicrob Agents. 2018;52:331-337.
    PubMed     Text format     Abstract available


    August 2018
  88. MOGLE BT, Steele JM, Seabury RW, Dang UJ, et al
    Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteremia.
    Int J Antimicrob Agents. 2018 Aug 31. pii: S0924-8579(18)30250.
    PubMed     Text format     Abstract available


  89. HE JM, Sun SC, Sun ZL, Chen JT, et al
    Isovalerylshikonin, a new resistance-modifying agent from Arnebia euchroma, supresses antibiotic resistance of drug-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. 2018 Aug 31. pii: S0924-8579(18)30247.
    PubMed     Text format     Abstract available


  90. RAOULT D
    The theory of "Eat me cake", or the genetic cannibalism of the enemy: a cause of vanishing antibiotic resistance.
    Int J Antimicrob Agents. 2018 Aug 24. pii: S0924-8579(18)30244.
    PubMed     Text format    


  91. LISHMAN H, Costelloe C, Hopkins S, Johnson AP, et al
    Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antibiotic resistance: an ecological study.
    Int J Antimicrob Agents. 2018 Aug 23. pii: S0924-8579(18)30239.
    PubMed     Text format     Abstract available


  92. SHIMA K, Ledig S, Loeper N, Schiefer A, et al
    Effective inhibition of rifampin-resistant Chlamydia trachomatis by the novel DNA-dependent RNA-polymerase inhibitor Corallopyronin A.
    Int J Antimicrob Agents. 2018 Aug 6. pii: S0924-8579(18)30224.
    PubMed     Text format    


  93. CARMEN L, Andrea DC, Eleonora M, Ilaria P, et al
    Assessing antibiotic resistance gene load in vegan, vegetarian and omnivore human gut microbiota.
    Int J Antimicrob Agents. 2018 Aug 3. pii: S0924-8579(18)30222.
    PubMed     Text format     Abstract available


  94. CHUANG L, Ratnayake L
    Overcoming challenges of treating extensively drug-resistant Acinetobacter baumannii bacteraemic urinary tract infection.
    Int J Antimicrob Agents. 2018 Aug 3. pii: S0924-8579(18)30207.
    PubMed     Text format    


  95. KLIBI A, Maaroufi A, Torres C, Jouini A, et al
    Detection and characterization of methicillin resistant and susceptible coagulase-negative Staphylococci in milk from cows with clinical mastitis in Tunisia.
    Int J Antimicrob Agents. 2018 Aug 2. pii: S0924-8579(18)30225.
    PubMed     Text format     Abstract available


  96. ZHANG X, Zhang Y, Wang F, Wang C, et al
    Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates.
    Int J Antimicrob Agents. 2018;52:226-232.
    PubMed     Text format     Abstract available


  97. FANG H, Feng J, Xu Y, Zhang Y, et al
    Sequencing of pT5282-CTXM, p13190-KPC and p30860-NR, and comparative genomics analysis of IncX8 plasmids.
    Int J Antimicrob Agents. 2018;52:210-217.
    PubMed     Text format     Abstract available


  98. GUO X, Wu J, Wei F, Ouyang Y, et al
    Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study.
    Int J Antimicrob Agents. 2018;52:201-209.
    PubMed     Text format     Abstract available


  99. RECIO R, Villa J, Viedma E, Orellana MA, et al
    Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
    Int J Antimicrob Agents. 2018;52:172-179.
    PubMed     Text format     Abstract available


  100. TAYLOR E, Sriskandan S, Woodford N, Hopkins KL, et al
    High prevalence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacteriaceae in the UK and Ireland.
    Int J Antimicrob Agents. 2018;52:278-282.
    PubMed     Text format     Abstract available


  101. GU D, Lv H, Sun Q, Shu L, et al
    Emergence of tet(A) and blaKPC-2 co-carrying plasmid from a ST11 hypervirulent Klebsiella pneumoniae isolate in patient's gut.
    Int J Antimicrob Agents. 2018;52:307-308.
    PubMed     Text format    


  102. NGUYEN LTT, Roman F, Morikawa K, Trincado P, et al
    Prevalence of pSCFS7-like vectors among cfr-positive staphylococcal population in Spain.
    Int J Antimicrob Agents. 2018;52:305-306.
    PubMed     Text format    


  103. LI R, Xie M, Chan EWC, Chen S, et al
    Rapid resolution of multi-drug resistance bacterial genome harbouring mcr-1 and blaCMY-2 using MinION sequencing platform.
    Int J Antimicrob Agents. 2018;52:303-304.
    PubMed     Text format    


  104. GREENWOOD B, Meunier D, Hopkins KL, Pike R, et al
    Pseudomonas aeruginosa sequence type 357 with VEB extended-spectrum beta-lactamases in the UK: relatedness and resistance.
    Int J Antimicrob Agents. 2018;52:301-302.
    PubMed     Text format    


    July 2018
  105. YAN Q, Karau MJ, Raval YS, Patel R, et al
    in vitro Activity of Oritavancin in Combination with Rifampin or Gentamicin Against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus epidermidis Biofilms.
    Int J Antimicrob Agents. 2018 Jul 23. pii: S0924-8579(18)30203.
    PubMed     Text format     Abstract available


  106. SANTONA A, Taviani E, Hoang HM, Fiamma M, et al
    Emergence of unusual vanA/vanB2 genotype in a highly mutated vanB2-Vancomycin Resistant Hospital Associated E. faecium background, in Vietnam.
    Int J Antimicrob Agents. 2018 Jul 13. pii: S0924-8579(18)30197.
    PubMed     Text format     Abstract available


  107. SEIFERT H, Blondeau J, Dowzicky MJ
    In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance - a report from the T.E.S.T. study.
    Int J Antimicrob Agents. 2018 Jul 13. pii: S0924-8579(18)30194.
    PubMed     Text format     Abstract available


  108. BARRADO L, Perez-Vazquez M, Del Pozo JL, Martin-Salas C, et al
    Clonal transmission of NDM-5-producing Escherichia coli belonging to high-risk sequence type ST405.
    Int J Antimicrob Agents. 2018;52:123-124.
    PubMed     Text format    


  109. MONACO F, Mento GD, Cuscino N, Conaldi PG, et al
    Infant colonisation with Escherichia coli and Klebsiella pneumoniae strains co-harbouring blaOXA-48 and blaNDM-1 carbapenemases genes: a case report.
    Int J Antimicrob Agents. 2018;52:121-122.
    PubMed     Text format    


  110. PEYCLIT L, Baron SA, Yousfi H, Rolain JM, et al
    Zidovudine: A salvage therapy for mcr-1 plasmid-mediated colistin-resistant bacterial infections?
    Int J Antimicrob Agents. 2018;52:11-13.
    PubMed     Text format    


  111. WANG J, Cao L, Yang X, Wu Q, et al
    Transcriptional analysis reveals the critical role of RNA polymerase-binding transcription factor, DksA, in regulating multi-drug resistance of Escherichia coli.
    Int J Antimicrob Agents. 2018;52:63-69.
    PubMed     Text format     Abstract available


  112. DOMHAN C, Uhl P, Meinhardt A, Zimmermann S, et al
    A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics.
    Int J Antimicrob Agents. 2018;52:52-62.
    PubMed     Text format     Abstract available


  113. GARCIA V, Garcia-Menino I, Mora A, Flament-Simon SC, et al
    Co-occurrence of mcr-1, mcr-4 and mcr-5 genes in multidrug-resistant ST10 Enterotoxigenic and Shiga toxin-producing Escherichia coli in Spain (2006-2017).
    Int J Antimicrob Agents. 2018;52:104-108.
    PubMed     Text format     Abstract available


  114. MOUBARECK CA, Mouftah SF, Pal T, Ghazawi A, et al
    Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.
    Int J Antimicrob Agents. 2018;52:90-95.
    PubMed     Text format     Abstract available


  115. MA Q, Huang Y, Wang J, Xu X, et al
    Multidrug-resistant Shigella sonnei carrying the plasmid-mediated mcr-1 gene in China.
    Int J Antimicrob Agents. 2018;52:14-21.
    PubMed     Text format     Abstract available


  116. SHUKLA M, Soni I, Matsuyama K, Tran T, et al
    Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2018;52:22-27.
    PubMed     Text format     Abstract available


  117. GIUFRE M, Errico G, Accogli M, Monaco M, et al
    Emergence of NDM-5-producing Escherichia coli sequence type 167 clone in Italy.
    Int J Antimicrob Agents. 2018;52:76-81.
    PubMed     Text format     Abstract available


  118. BULMAN ZP, Zhao M, Satlin MJ, Chen L, et al
    Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
    Int J Antimicrob Agents. 2018;52:114-118.
    PubMed     Text format     Abstract available


    June 2018
  119. LIN YT, Cheng YH, Juan CH, Wu PF, et al
    High mortality among patients infected with hypervirulent antimicrobial-resistant capsular type K1 Klebsiella pneumoniae strains in Taiwan.
    Int J Antimicrob Agents. 2018 Jun 12. pii: S0924-8579(18)30165.
    PubMed     Text format     Abstract available


  120. MITGANG EA, Hartley DM, Malchione MD, Koch M, et al
    Review and Mapping of Carbapenem-resistant Enterobacteriaceae in Africa: Using Diverse Data to Inform Surveillance Gaps.
    Int J Antimicrob Agents. 2018 Jun 1. pii: S0924-8579(18)30157.
    PubMed     Text format     Abstract available


  121. YOKOTA SI, Hakamada H, Yamamoto S, Sato T, et al
    Release of large amounts of lipopolysaccharides from Pseudomonas aeruginosa cells reduces their susceptibility to colistin.
    Int J Antimicrob Agents. 2018;51:888-896.
    PubMed     Text format     Abstract available


  122. ALONSO CA, Cortes-Cortes G, Maamar E, Masso M, et al
    Molecular diversity and conjugal transferability of class 2 integrons among Escherichia coli isolates from food, animal and human sources.
    Int J Antimicrob Agents. 2018;51:905-911.
    PubMed     Text format     Abstract available


  123. PETER S, Bezdan D, Oberhettinger P, Vogel W, et al
    Whole-genome sequencing enabling the detection of a colistin-resistant hypermutating Citrobacter werkmanii strain harbouring a novel metallo-beta-lactamase VIM-48.
    Int J Antimicrob Agents. 2018;51:867-874.
    PubMed     Text format     Abstract available


  124. PFALLER MA, Huband MD, Streit JM, Flamm RK, et al
    Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).
    Int J Antimicrob Agents. 2018;51:848-853.
    PubMed     Text format     Abstract available


  125. SUN J, Li XP, Fang LX, Sun RY, et al
    Co-occurrence of mcr-1 in the chromosome and on an IncHI2 plasmid: persistence of colistin resistance in Escherichia coli.
    Int J Antimicrob Agents. 2018;51:842-847.
    PubMed     Text format     Abstract available


  126. PEROZZIELLO A, Routelous C, Charani E, Truel A, et al
    Experiences and perspectives of implementing antimicrobial stewardship in five French hospitals: a qualitative study.
    Int J Antimicrob Agents. 2018;51:829-835.
    PubMed     Text format     Abstract available


  127. ZHOU K, Luo Q, Wang Q, Huang C, et al
    Silent transmission of an IS1294b-deactivated mcr-1 gene with inducible colistin resistance.
    Int J Antimicrob Agents. 2018;51:822-828.
    PubMed     Text format     Abstract available


  128. LIU J, Yang Y, Li Y, Liu D, et al
    Isolation of an IncP-1 plasmid harbouring mcr-1 from a chicken isolate of Citrobacter braakii in China.
    Int J Antimicrob Agents. 2018;51:936-940.
    PubMed     Text format     Abstract available


    May 2018
  129. MAFIZ A, Perera LN, He Y, Zhang W, et al
    A Case Study on Soil Antibiotic Resistome in an Urban Community Garden.
    Int J Antimicrob Agents. 2018 May 29. pii: S0924-8579(18)30147.
    PubMed     Text format     Abstract available


  130. MENICHETTI F, Falcone M, Lopalco P, Tascini C, et al
    The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy.
    Int J Antimicrob Agents. 2018 May 23. pii: S0924-8579(18)30141.
    PubMed     Text format     Abstract available


  131. YAHIA HB, Chairat S, Hamdi N, Gharsa H, et al
    Antimicrobial resistance and genetic lineages of faecal enterococci of wild birds: Emergence of vanA and vanB2 harboring Enterococcus faecalis.
    Int J Antimicrob Agents. 2018 May 14. pii: S0924-8579(18)30136.
    PubMed     Text format     Abstract available


  132. LIU YH, Huang YT, Liao CH, Hsueh PR, et al
    Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001-2013 with an emphasis on high rate of azithromycin resistance among the isolates.
    Int J Antimicrob Agents. 2018;51:768-774.
    PubMed     Text format     Abstract available


  133. OKDAH L, Le Page S, Olaitan AO, Dubourg G, et al
    New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
    Int J Antimicrob Agents. 2018;51:775-783.
    PubMed     Text format     Abstract available


  134. WANG R, Liu Y, Zhang Q, Jin L, et al
    The prevalence of colistin resistance in Escherichia coli and Klebsiella pneumoniae isolated from food animals in China: coexistence of mcr-1 and blaNDM with low fitness cost.
    Int J Antimicrob Agents. 2018;51:739-744.
    PubMed     Text format     Abstract available


  135. SORSTEDT E, Carlander C, Flamholc L, Hejdeman B, et al
    Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations.
    Int J Antimicrob Agents. 2018;51:733-738.
    PubMed     Text format     Abstract available


  136. THABIT AK, Monogue ML, Newman JV, Nicolau DP, et al
    Assessment of in vivo efficacy of eravacycline against Enterobacteriaceae exhibiting various resistance mechanisms: a dose-ranging study and pharmacokinetic/pharmacodynamic analysis.
    Int J Antimicrob Agents. 2018;51:727-732.
    PubMed     Text format     Abstract available


  137. RADDAOUI A, Ben Tanfous F, Achour W, Baaboura R, et al
    Description of a novel mutation in the atpC gene in optochin-resistant Streptococcus pneumoniae strains isolates from Tunisia.
    Int J Antimicrob Agents. 2018;51:803-805.
    PubMed     Text format     Abstract available


  138. MERCURO NJ, Stogsdill P, Wungwattana M
    Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus beta-lactams.
    Int J Antimicrob Agents. 2018;51:687-692.
    PubMed     Text format     Abstract available


  139. FERREIRA ML, Goncalves IR, Araujo BF, Royer S, et al
    Detection of ISEcp1-associated blaCTX-M-15-mediated resistance to colistin in KPC-producing Klebsiella pneumoniae isolates.
    Int J Antimicrob Agents. 2018;51:810-811.
    PubMed     Text format    


    April 2018
  140. RADDAOUI A, Tanfous FB, Chebbi Y, Achour W, et al
    High prevalence of multidrug resistant international clones among macrolide resistant Streptococcus pneumoniae strains in immunocompromised Patients in Tunisia.
    Int J Antimicrob Agents. 2018 Apr 23. pii: S0924-8579(18)30117.
    PubMed     Text format     Abstract available


  141. LEINWEBER H, Alotaibi SMI, Overballe-Petersen S, Hansen F, et al
    Vancomycin resistance in Enterococcus faecium isolated from Danish chicken meat is located on a pVEF4-like plasmid persisting in poultry for 18 years.
    Int J Antimicrob Agents. 2018 Apr 2. pii: S0924-8579(18)30097.
    PubMed     Text format     Abstract available


  142. HAMZAOUI Z, Ocampo-Sosa A, Martinez MF, Landolsi S, et al
    Role of association of OmpK35 and OmpK36 alteration and blaESBL and/or blaAmpC in conferring carbapenem resistance among non-producing carbapenemase-Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2018 Apr 2. pii: S0924-8579(18)30098.
    PubMed     Text format     Abstract available


  143. ADHIKARI S, Piza M, Taylor P, Deshpande K, et al
    Sustained multimodal antimicrobial stewardship in an Australian tertiary intensive care unit from 2008-2015: an interrupted time-series analysis.
    Int J Antimicrob Agents. 2018;51:620-628.
    PubMed     Text format     Abstract available


  144. OHNUMA T, Hayashi Y, Yamashita K, Marquess J, et al
    A nationwide survey of intravenous antimicrobial use in intensive care units in Japan.
    Int J Antimicrob Agents. 2018;51:636-641.
    PubMed     Text format     Abstract available


  145. VARDAKAS KZ, Mavroudis AD, Georgiou M, Falagas ME, et al
    Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;51:535-547.
    PubMed     Text format     Abstract available


  146. HUANG J, Zhu Y, Han ML, Li M, et al
    Comparative analysis of phosphoethanolamine transferases involved in polymyxin resistance across 10 clinically relevant Gram-negative bacteria.
    Int J Antimicrob Agents. 2018;51:586-593.
    PubMed     Text format     Abstract available


  147. CARRARA E, Pfeffer I, Zusman O, Leibovici L, et al
    Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;51:548-553.
    PubMed     Text format     Abstract available


  148. PFALLER MA, Flamm RK, Castanheira M, Sader HS, et al
    Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016).
    Int J Antimicrob Agents. 2018;51:608-611.
    PubMed     Text format     Abstract available


  149. NGUYEN PC, Madani A, Santucci P, Martin BP, et al
    Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases.
    Int J Antimicrob Agents. 2018;51:651-654.
    PubMed     Text format     Abstract available


  150. LI R, Yu H, Xie M, Chen K, et al
    Genetic basis of chromosomally-encoded mcr-1 gene.
    Int J Antimicrob Agents. 2018;51:578-585.
    PubMed     Text format     Abstract available


  151. TIETGEN M, Semmler T, Riedel-Christ S, Kempf VAJ, et al
    Impact of the colistin resistance gene mcr-1 on bacterial fitness.
    Int J Antimicrob Agents. 2018;51:554-561.
    PubMed     Text format     Abstract available


  152. LINDGREN AK, Nilsson AC, Akesson P, Gustafsson E, et al
    Eradication of methicillin-resistant Staphylococcus aureus (MRSA) throat carriage: a randomised trial comparing topical treatment with rifampicin-based systemic therapy.
    Int J Antimicrob Agents. 2018;51:642-645.
    PubMed     Text format     Abstract available


    March 2018
  153. OH E, Bae J, Kumar A, Choi HJ, et al
    Antioxidant-based synergistic eradication of methicillin-resistant Staphylococcus aureus (MRSA) biofilms with bacitracin.
    Int J Antimicrob Agents. 2018 Mar 19. pii: S0924-8579(18)30077.
    PubMed     Text format     Abstract available


  154. SANTOS L, Ramos F
    Antimicrobial resistance in aquaculture: current knowledge and alternatives to tackle the problem.
    Int J Antimicrob Agents. 2018 Mar 19. pii: S0924-8579(18)30081.
    PubMed     Text format     Abstract available


  155. FALAGAS ME, Skalidis T, Vardakas KZ, Voulgaris GL, et al
    Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals.
    Int J Antimicrob Agents. 2018 Mar 17. pii: S0924-8579(18)30080.
    PubMed     Text format     Abstract available


  156. PFALLER MA, Huband MD, Mendes RE, Flamm RK, et al
    In vitro activity of meropenem-vaborbactam and characterization of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem-vaborbactam surveillance program.
    Int J Antimicrob Agents. 2018 Mar 3. pii: S0924-8579(18)30064.
    PubMed     Text format     Abstract available


  157. HUANG YT, Liao CH, Chen SY, Hsu HS, et al
    Emergence of multidrug-resistant sequence type 45 strains among borderline oxacillin-resistant mecA-positive Staphylococcus aureus causing bacteraemia in a medical centre in Taiwan.
    Int J Antimicrob Agents. 2018 Mar 2. pii: S0924-8579(18)30052.
    PubMed     Text format     Abstract available


  158. VINUE L, Hooper DC, Jacoby GA
    Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coli.
    Int J Antimicrob Agents. 2018;51:479-483.
    PubMed     Text format     Abstract available


  159. JONES BM, Hersey RM, Trestman IJ, Bland CM, et al
    Successful treatment of a penicillin-intermediate and ceftriaxone-resistant Granulicatella adiacens presumed prosthetic valve endocarditis with vancomycin.
    Int J Antimicrob Agents. 2018;51:508-510.
    PubMed     Text format     Abstract available


  160. DIETL B, Sanchez I, Arcenillas P, Cuchi E, et al
    Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.
    Int J Antimicrob Agents. 2018;51:498-502.
    PubMed     Text format     Abstract available


  161. BOUSQUET A, Bugier S, Larreche S, Bigaillon C, et al
    Clinical isolates of Escherichia coli solely resistant to mecillinam: prevalence and epidemiology.
    Int J Antimicrob Agents. 2018;51:493-497.
    PubMed     Text format     Abstract available


  162. KHAN DD, Lagerback P, Malmberg C, Kristoffersson AN, et al
    Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli.
    Int J Antimicrob Agents. 2018;51:399-406.
    PubMed     Text format     Abstract available


  163. HE J, Jia X, Yang S, Xu X, et al
    Heteroresistance to carbapenems in invasive Pseudomonas aeruginosa infections.
    Int J Antimicrob Agents. 2018;51:413-421.
    PubMed     Text format     Abstract available


  164. BRAUN G, Cayo R, Matos AP, de Mello Fonseca J, et al
    Temporal evolution of polymyxin B-resistant Klebsiella pneumoniae clones recovered from blood cultures in a teaching hospital during a 7-year period.
    Int J Antimicrob Agents. 2018;51:522-527.
    PubMed     Text format     Abstract available


  165. CHIEN YC, Liao CH, Sheng WH, Chien JY, et al
    Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
    Int J Antimicrob Agents. 2018;51:357-364.
    PubMed     Text format     Abstract available


  166. TACAO M, Araujo S, Vendas M, Alves A, et al
    Shewanella species as the origin of blaOXA-48 genes: insights into gene diversity, associated phenotypes and possible transfer mechanisms.
    Int J Antimicrob Agents. 2018;51:340-348.
    PubMed     Text format     Abstract available


  167. HERNANDEZ M, Quijada NM, Lorente LL, de Frutos M, et al
    Infrequent isolation of extensively drug-resistant (XDR) Klebsiella pneumoniae resistant to colistin in Spain.
    Int J Antimicrob Agents. 2018;51:531-533.
    PubMed     Text format    


  168. BERNASCONI OJ, Dona V, Pires J, Kuenzli E, et al
    Deciphering the complete deletion of the mgrB locus in an unusual colistin-resistant Klebsiella pneumoniae isolate colonising the gut of a traveller returning from India.
    Int J Antimicrob Agents. 2018;51:529-531.
    PubMed     Text format    


  169. SCHIRMEIER E, Zimmermann P, Hofmann V, Biebl M, et al
    Inhibitory and bactericidal effect of Artilysin((R)) Art-175 against colistin-resistant mcr-1-positive Escherichia coli isolates.
    Int J Antimicrob Agents. 2018;51:528-529.
    PubMed     Text format    


    February 2018
  170. STEWART A, Roberts JA, Wallis SC, Allworth AM, et al
    Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat A carbapenem-resistant Pseudomonas aeruginosa lung abscess on an outpatient antimicrobial program.
    Int J Antimicrob Agents. 2018 Feb 19. pii: S0924-8579(18)30046.
    PubMed     Text format    


  171. VUBIL D, Balleste-Delpierre C, Mabunda R, Acacio S, et al
    Antibiotic resistance and molecular characterization of Shigella isolates recovered from children less than 5 years in Manhica, Southern Mozambique.
    Int J Antimicrob Agents. 2018 Feb 12. pii: S0924-8579(18)30043.
    PubMed     Text format     Abstract available


  172. MOHAMMAD H, AbdelKhalek A, Abutaleb NS, Seleem MN, et al
    Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci.
    Int J Antimicrob Agents. 2018 Feb 9. pii: S0924-8579(18)30041.
    PubMed     Text format     Abstract available


  173. SANTEVECCHI BA, Smith TT, MacVane SH
    Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than klebsiella pneumoniae.
    Int J Antimicrob Agents. 2018 Feb 2. pii: S0924-8579(18)30019.
    PubMed     Text format     Abstract available


  174. SEO MR, Kim J, Lee Y, Lim DG, et al
    Prevalence, genetic relatedness and antibiotic resistance of hospital-acquired clostridium difficile PCR ribotype 018 strains.
    Int J Antimicrob Agents. 2018 Feb 2. pii: S0924-8579(18)30036.
    PubMed     Text format     Abstract available


  175. BARTOLETTI M, Tedeschi S, Pascale R, Raumer L, et al
    Differences in the rate of carbapenem-resistant enterobacteriaceae colonization or clostridium difficile infection following frontline treatment with tigecycline versus meropenem for intra-abdominal infections.
    Int J Antimicrob Agents. 2018 Feb 1. pii: S0924-8579(18)30013.
    PubMed     Text format     Abstract available


  176. JAIDANE N, Naas T, Mansour W, Radhia BB, et al
    Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
    Int J Antimicrob Agents. 2018;51:266-269.
    PubMed     Text format     Abstract available


  177. GHAZI IM, Monogue ML, Tsuji M, Nicolau DP, et al
    Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model.
    Int J Antimicrob Agents. 2018;51:206-212.
    PubMed     Text format     Abstract available


  178. AGNOLETTI F, Brunetta R, Bano L, Drigo I, et al
    Longitudinal study on antimicrobial consumption and resistance in rabbit farming.
    Int J Antimicrob Agents. 2018;51:197-205.
    PubMed     Text format     Abstract available


  179. GIORDANO C, Barnini S, Tsioutis C, Chlebowicz MA, et al
    Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids.
    Int J Antimicrob Agents. 2018;51:260-265.
    PubMed     Text format     Abstract available


  180. KAUSHIK M, Kumar S, Kapoor RK, Virdi JS, et al
    Integrons in Enterobacteriaceae: diversity, distribution and epidemiology.
    Int J Antimicrob Agents. 2018;51:167-176.
    PubMed     Text format     Abstract available


  181. CABANEL N, Bouchier C, Rajerison M, Carniel E, et al
    Plasmid-mediated doxycycline resistance in a Yersinia pestis strain isolated from a rat.
    Int J Antimicrob Agents. 2018;51:249-254.
    PubMed     Text format     Abstract available


  182. PFALLER MA, Shortridge D, Sader HS, Castanheira M, et al
    Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillanc
    Int J Antimicrob Agents. 2018;51:181-189.
    PubMed     Text format     Abstract available


  183. HILLE K, Roschanski N, Ruddat I, Woydt J, et al
    Investigation of potential risk factors for the occurrence of Escherichia coli isolates from German fattening pig farms harbouring the mcr-1 colistin-resistance gene.
    Int J Antimicrob Agents. 2018;51:177-180.
    PubMed     Text format     Abstract available


  184. SEIFERT H, Korber-Irrgang B, Kresken M
    In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany.
    Int J Antimicrob Agents. 2018;51:227-234.
    PubMed     Text format     Abstract available


  185. LARSSON DGJ
    Risks of using the natural defence of commensal bacteria as antibiotics call for research and regulation.
    Int J Antimicrob Agents. 2018;51:277-278.
    PubMed     Text format    


  186. ZHENG B, Lv T, Xu H, Yu X, et al
    Discovery and characterisation of an escherichia coli ST206 strain producing NDM-5 and MCR-1 from a patient with acute diarrhoea in China.
    Int J Antimicrob Agents. 2018;51:273-275.
    PubMed     Text format    


  187. CHIEM K, Hue F, Magallon J, Tolmasky ME, et al
    Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance by zinc complexed with clioquinol, an ionophore active against tumors and neurodegenerative diseases.
    Int J Antimicrob Agents. 2018;51:271-273.
    PubMed     Text format    


  188. HO PL, Yau CY, Wang Y, Chow KH, et al
    Determination of the mutant-prevention concentration of imipenem for the two imipenem-susceptible Bacteroides fragilis strains, Q1F2 (cfiA-positive) and ATCC 25282 (cfiA-negative).
    Int J Antimicrob Agents. 2018;51:270-271.
    PubMed     Text format    


    January 2018
  189. LIN YT, Hung WC, Tsai JC, Leong KH, et al
    Wide dissemination of SCCfusC in fusidic acid resistant coagulase-negative staphylococci and implication for its spreading to methicillin-resistant S. aureus in Taiwan.
    Int J Antimicrob Agents. 2018 Jan 30. pii: S0924-8579(18)30031.
    PubMed     Text format     Abstract available


  190. GARCIA-CASTILLO M, Garcia-Fernandez S, Gomez-Gil R, Pitart C, et al
    Activity of ceftazidime-avibactam against carbapenemase-producing enterobacteriaceae from urine samples obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
    Int J Antimicrob Agents. 2018 Jan 22. pii: S0924-8579(18)30014.
    PubMed     Text format     Abstract available


  191. ZHANG G, Lin X, Cai J, Zhang R, et al
    Characteristics of clinical and environmental vanM-carrying vancomycin-resistant enterococci isolates from an infected patient.
    Int J Antimicrob Agents. 2018 Jan 12. pii: S0924-8579(18)30006.
    PubMed     Text format     Abstract available


  192. LIEGEON G, Delory T, Picardeau M
    Antibiotic susceptibilities of livestock isolates of leptospira.
    Int J Antimicrob Agents. 2018 Jan 3. pii: S0924-8579(17)30467.
    PubMed     Text format     Abstract available


  193. LU M, Yu C, Cui X, Shi J, et al
    Gentamicin synergises with azoles against drug-resistant Candida albicans.
    Int J Antimicrob Agents. 2018;51:107-114.
    PubMed     Text format     Abstract available


  194. LIU J, Yang L, Chen D, Peters BM, et al
    Complete sequence of pBM413, a novel multidrug resistance megaplasmid carrying qnrVC6 and blaIMP-45 from pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2018;51:145-150.
    PubMed     Text format     Abstract available


  195. WANG R, Liu H, Zhao X, Li J, et al
    IncA/C plasmids conferring high azithromycin resistance in vibrio cholerae.
    Int J Antimicrob Agents. 2018;51:140-144.
    PubMed     Text format     Abstract available


  196. PARVEZ S, Khan AU
    Hospital sewage water: a reservoir for variants of New Delhi metallo-beta-lactamase (NDM)- and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.
    Int J Antimicrob Agents. 2018;51:82-88.
    PubMed     Text format     Abstract available


  197. VESTERGAARD M, Nohr-Meldgaard K, Ingmer H
    Multiple pathways towards reduced membrane potential and concomitant reduction in aminoglycoside susceptibility in Staphylococcus aureus.
    Int J Antimicrob Agents. 2018;51:132-135.
    PubMed     Text format     Abstract available


  198. LUO HY, Liu MF, Wang MS, Zhao XX, et al
    A novel resistance gene, lnu(H), conferring resistance to lincosamides in Riemerella anatipestifer CH-2.
    Int J Antimicrob Agents. 2018;51:136-139.
    PubMed     Text format     Abstract available


  199. SEIFERT H, Stefanik D, Sutcliffe JA, Higgins PG, et al
    In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
    Int J Antimicrob Agents. 2018;51:62-64.
    PubMed     Text format     Abstract available


  200. VARDAKAS KZ, Voulgaris GL, Samonis G, Falagas ME, et al
    Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;51:1-9.
    PubMed     Text format     Abstract available


  201. PELLON A, Ramirez-Garcia A, Buldain I, Antoran A, et al
    Pathobiology of Lomentospora prolificans: could this species serve as a model of primary antifungal resistance?
    Int J Antimicrob Agents. 2018;51:10-15.
    PubMed     Text format     Abstract available


  202. VIEL A, Henri J, Perrin-Guyomard A, Laroche J, et al
    Lack of experimental evidence to support mcr-1-positive Escherichia coli strain selection during oral administration of colistin at recommended and higher dose given by gavage in weaned piglets.
    Int J Antimicrob Agents. 2018;51:128-131.
    PubMed     Text format     Abstract available


  203. PEETERS LEJ, Croubels S, Rasschaert G, Imberechts H, et al
    Effect of residual doxycycline concentrations on resistance selection and transfer in porcine commensal Escherichia coli.
    Int J Antimicrob Agents. 2018;51:123-127.
    PubMed     Text format     Abstract available


  204. FUKUDA A, Sato T, Shinagawa M, Takahashi S, et al
    High prevalence of mcr-1, mcr-3 and mcr-5 in Escherichia coli derived from diseased pigs in Japan.
    Int J Antimicrob Agents. 2018;51:163-164.
    PubMed     Text format    


    December 2017
  205. WI YM, Greenwood-Quaintance KE, Brinkman CL, Lee JYH, et al
    Rifampin resistance in staphylococcus epidermidis: molecular characterization and fitness cost of rpoB mutations.
    Int J Antimicrob Agents. 2017 Dec 26. pii: S0924-8579(17)30453.
    PubMed     Text format     Abstract available


  206. VARGAS-ALZATE CA, Higuita-Gutierrez LF, Lopez Lopez L, Cienfuegos Gallet AV, et al
    High excess costs of infections caused by carbapenem-resistant gram-negative bacilli in an endemic region.
    Int J Antimicrob Agents. 2017 Dec 22. pii: S0924-8579(17)30446.
    PubMed     Text format     Abstract available


  207. DIEZ-AGUILAR M, Conejo MC, Morosini MI, Palop NT, et al
    Susceptibility testing and detection of beta-lactam resistance mechanisms in enterobacteriaceae: a multicentre national proficiency study.
    Int J Antimicrob Agents. 2017 Dec 21. pii: S0924-8579(17)30442.
    PubMed     Text format     Abstract available


  208. CHUSRI S, Sakarunchai I, Kositpantawong N, Panthuwong S, et al
    Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2017 Dec 11. pii: S0924-8579(17)30436.
    PubMed     Text format     Abstract available


    November 2017
  209. BROWN-JAQUE M, Calero-Caceres W, Espinal P, Rodriguez-Navarro J, et al
    Antibiotic resistance genes in phage particles isolated from human feces and induced from clinical bacterial isolates.
    Int J Antimicrob Agents. 2017 Nov 24. pii: S0924-8579(17)30431.
    PubMed     Text format     Abstract available


  210. BERGLUND B, Hoang NTB, Tarnberg M, Le NK, et al
    Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant klebsiella pneumoniae from vietnam.
    Int J Antimicrob Agents. 2017 Nov 24. pii: S0924-8579(17)30429.
    PubMed     Text format     Abstract available


  211. FREITAS AR, Novais C, Duarte B, Pereira AP, et al
    High rates of colonization by ampicillin-resistant enterococci in residents at long-term care facilities in Porto, Portugal.
    Int J Antimicrob Agents. 2017 Nov 23. pii: S0924-8579(17)30418.
    PubMed     Text format     Abstract available


  212. LI W, Liu JH, Zhang XF, Wang J, et al
    Emergence of methicillin-resistant staphylococcus aureus ST398 in pigs in china.
    Int J Antimicrob Agents. 2017 Nov 6. pii: S0924-8579(17)30386.
    PubMed     Text format    


  213. YEON PS, Jung LE, Tark K, Nae YS, et al
    Early administration of appropriate antimicrobial agent to improve the outcome of carbapenem resistant acinetobacter baumannii complex bacteremic pneumonia.
    Int J Antimicrob Agents. 2017 Nov 6. pii: S0924-8579(17)30391.
    PubMed     Text format     Abstract available


    October 2017
  214. IDELEVICH EA, Hoy M, Knaack D, Gorlich D, et al
    Direct determination of carbapenem-resistant enterobacteriaceae and pseudomonas aeruginosa from positive blood cultures using laser scattering technology.
    Int J Antimicrob Agents. 2017 Oct 27. pii: S0924-8579(17)30373.
    PubMed     Text format     Abstract available


  215. SOBKE A, Makarewicz O, Baier M, Bar C, et al
    Empiric treatment of lower urinary tract infections in the face of spreading multi-drug resistance: in vitro study of nitroxoline effectiveness.
    Int J Antimicrob Agents. 2017 Oct 27. pii: S0924-8579(17)30374.
    PubMed     Text format     Abstract available


    September 2017
  216. CAMPOS J, Mourao J, Silveira L, Saraiva M, et al
    Imported poultry meat as a source of extended-spectrum cephalosporin-resistant CMY-2-producing salmonella heidelberg and s. minnesota in european union, 2014-2015.
    Int J Antimicrob Agents. 2017 Sep 14. pii: S0924-8579(17)30346.
    PubMed     Text format     Abstract available


    August 2017
  217. GIANNELLA M, Trecarichi EM, Giacobbe DR, De FG, et al
    Effect of combination therapy containing a high dose carbapenem on mortality in patients with carbapenem-resistant klebsiella pneumoniae bloodstream infection.
    Int J Antimicrob Agents. 2017 Aug 22. pii: S0924-8579(17)30311.
    PubMed     Text format     Abstract available


  218. GUNATHILAKA GU, Tahlan V, Mafiz A, Polur M, et al
    Phage in urban wastewater have the potential to disseminate antibiotic resistance.
    Int J Antimicrob Agents. 2017 Aug 10. pii: S0924-8579(17)30305.
    PubMed     Text format     Abstract available


    July 2017
  219. LOPEZ-CAUSAPE C, de Dios-Caballero J, Cobo M, Escribano A, et al
    Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
    Int J Antimicrob Agents. 2017 Jul 20. pii: S0924-8579(17)30284.
    PubMed     Text format     Abstract available


  220. ZHAO L, Liu A, Li R, Zhao S, et al
    Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
    Int J Antimicrob Agents. 2017 Jul 17. pii: S0924-8579(17)30214.
    PubMed     Text format     Abstract available


  221. BOUZID F, Astier H, Osman DA, Javelle E, et al
    Extended spectrum of antibiotic susceptibility for tuberculosis, djibouti.
    Int J Antimicrob Agents. 2017 Jul 12. pii: S0924-8579(17)30282.
    PubMed     Text format     Abstract available


  222. HOLZKNECHT BJ, Pinholt M, Gumpert H, Hammerum AM, et al
    Genetic characterization confirms sporadic occurrence of vancomycin-resistant Enterococcus faecalis in Copenhagen, Denmark.
    Int J Antimicrob Agents. 2017 Jul 11. pii: S0924-8579(17)30262.
    PubMed     Text format    


  223. BERNABE KJ, Langendorf C, Ford N, Ronat JB, et al
    Antibiotic resistance in West Africa: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2017 Jul 10. pii: S0924-8579(17)30274.
    PubMed     Text format     Abstract available


  224. SUTERA V, Hoarau G, Renesto P, Caspar Y, et al
    In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in francisella tularensis, including in tularaemia patients with treatment failure.
    Int J Antimicrob Agents. 2017 Jul 6. pii: S0924-8579(17)30251.
    PubMed     Text format     Abstract available


  225. WHITE BP, Stover KR, Barber KE, Galloway RC, et al
    Mechanisms of Fosfomycin Resistance in Carbapenem-Resistant Enterobacter spp.
    Int J Antimicrob Agents. 2017 Jul 5. pii: S0924-8579(17)30203.
    PubMed     Text format     Abstract available


  226. LEE MR, Chien JY, Huang YT, Liao CH, et al
    Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
    Int J Antimicrob Agents. 2017;50:35-40.
    PubMed     Text format     Abstract available


  227. SPARHAM SJ, Kwong JC, Valcanis M, Easton M, et al
    Emergence of multidrug resistance in locally-acquired human infections with Salmonella Typhimurium in Australia owing to a new clade harbouring blaCTX-M-9.
    Int J Antimicrob Agents. 2017;50:101-105.
    PubMed     Text format     Abstract available


    June 2017
  228. CLAEYS KC, Zasowski EJ, Lagnf AM, Levine DP, et al
    Novel Application of Published Risk Factors for Methicillin-Resistant S. aureus in Acute Bacterial Skin and Skin Structure Infections.
    Int J Antimicrob Agents. 2017 Jun 28. pii: S0924-8579(17)30226.
    PubMed     Text format     Abstract available


  229. CHIEN JY, Yu CJ, Hsueh PR
    High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan.
    Int J Antimicrob Agents. 2017 Jun 28. pii: S0924-8579(17)30207.
    PubMed     Text format     Abstract available


  230. SHAH KJ, Cherabuddi K, Shultz J, Borgert S, et al
    Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin resistant enterococcus spp (VRE): a single-center university hospital experience.
    Int J Antimicrob Agents. 2017 Jun 27. pii: S0924-8579(17)30218.
    PubMed     Text format     Abstract available


  231. FERLOV-SCHWENSEN SA, Sydenham TV, Hansen KC, Hoegh SV, et al
    Prevalences of antimicrobial resistance and the cfiA resistance gene in danish bacteroides fragilis group isolates since 1973.
    Int J Antimicrob Agents. 2017 Jun 27. pii: S0924-8579(17)30198.
    PubMed     Text format     Abstract available


  232. KELLY AM, Mathema B, Larson EL
    Carbapenem-resistant Enterobacteriaceae in the community: a scoping review.
    Int J Antimicrob Agents. 2017 Jun 21. pii: S0924-8579(17)30192.
    PubMed     Text format     Abstract available


  233. SORANOGLOU V, Galanopoulos I, Giamarellos-Bourboulis EJ, Papalois A, et al
    Efficacy of intramuscular moxifloxacin in the treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus.
    Int J Antimicrob Agents. 2017 Jun 1. pii: S0924-8579(17)30175.
    PubMed     Text format     Abstract available


  234. MOROZUMI M, Okada T, Tajima T, Ubukata K, et al
    Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae.
    Int J Antimicrob Agents. 2017 Jun 1. pii: S0924-8579(17)30174.
    PubMed     Text format     Abstract available


  235. LI QJ, Jiao WW, Yin QQ, Li YJ, et al
    Positive epistasis of major low-cost drug resistance mutations rpoB531-TTG and katG315-ACC depends on the phylogenetic background of Mycobacterium tuberculosis strains.
    Int J Antimicrob Agents. 2017;49:757-762.
    PubMed     Text format     Abstract available


  236. DAHDOUH E, Gomez-Gil R, Sanz S, Gonzalez-Zorn B, et al
    A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Int J Antimicrob Agents. 2017;49:727-733.
    PubMed     Text format     Abstract available


  237. WI YM, Choi JY, Lee JY, Kang CI, et al
    Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea.
    Int J Antimicrob Agents. 2017;49:767-769.
    PubMed     Text format     Abstract available


  238. LIANG Q, Yin Z, Zhao Y, Liang L, et al
    Sequencing and comparative genomics analysis of the IncHI2 plasmids pT5282-mphA and p112298-catA and the IncHI5 plasmid pYNKP001-dfrA.
    Int J Antimicrob Agents. 2017;49:709-718.
    PubMed     Text format     Abstract available


    May 2017
  239. LOPEZ-DIAZ MC, Rios E, Rodriguez-Avial I, Simaluiza RJ, et al
    In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents.
    Int J Antimicrob Agents. 2017 May 31. pii: S0924-8579(17)30172.
    PubMed     Text format     Abstract available


  240. BOURDELLON L, Thilly N, Fougnot S, Pulcini C, et al
    Impact of selective reporting of antibiotic susceptibility test results on the appropriateness of antibiotics chosen by french general practitioners in urinary tract infections: a randomised controlled case-vignette study.
    Int J Antimicrob Agents. 2017 May 31. pii: S0924-8579(17)30173.
    PubMed     Text format     Abstract available


  241. JAILLARD M, van Belkum A, Cady KC, Creely D, et al
    Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2017 May 26. pii: S0924-8579(17)30163.
    PubMed     Text format     Abstract available


  242. DUPIEUX C, Kolenda C, Larsen AR, Pichon B, et al
    Variable performance of four commercial chromogenic media for detection of methicillin-resistant Staphylococcus aureus isolates harbouring mecC.
    Int J Antimicrob Agents. 2017 May 23. pii: S0924-8579(17)30166.
    PubMed     Text format     Abstract available


  243. QIN X, Tran BG, Kim MJ, Wang L, et al
    A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.
    Int J Antimicrob Agents. 2017;49:579-588.
    PubMed     Text format     Abstract available


  244. BROUQUI P, Quenard F, Drancourt M
    Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
    Int J Antimicrob Agents. 2017;49:554-557.
    PubMed     Text format     Abstract available


  245. CAI X, Yang Z, Dai J, Chen K, et al
    Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
    Int J Antimicrob Agents. 2017;49:609-616.
    PubMed     Text format     Abstract available


  246. JEANNOT K, Bolard A, Plesiat P
    Resistance to polymyxins in Gram-negative organisms.
    Int J Antimicrob Agents. 2017;49:526-535.
    PubMed     Text format     Abstract available


  247. ZAYYAD H, Eliakim-Raz N, Leibovici L, Paul M, et al
    Revival of old antibiotics: needs, the state of evidence and expectations.
    Int J Antimicrob Agents. 2017;49:536-541.
    PubMed     Text format     Abstract available


  248. KAYE KS, Gales AC, Dubourg G
    Old antibiotics for multidrug-resistant pathogens: from in vitro activity to clinical outcomes.
    Int J Antimicrob Agents. 2017;49:542-548.
    PubMed     Text format     Abstract available


  249. DUBOURG G, Abat C, Raoult D
    Why new antibiotics are not obviously useful now.
    Int J Antimicrob Agents. 2017;49:549-553.
    PubMed     Text format     Abstract available


    April 2017
  250. BI W, Li B, Song J, Hong Y, et al
    Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum beta-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
    Int J Antimicrob Agents. 2017 Apr 26. pii: S0924-8579(17)30135.
    PubMed     Text format     Abstract available


  251. CHANG YT, Coombs G, Ling T, Balaji V, et al
    Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013.
    Int J Antimicrob Agents. 2017 Apr 20. pii: S0924-8579(17)30121.
    PubMed     Text format     Abstract available


  252. KRAPP F, Grant JL, Sutton SH, Ozer EA, et al
    Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation.
    Int J Antimicrob Agents. 2017 Apr 4. pii: S0924-8579(17)30105.
    PubMed     Text format     Abstract available


  253. BI Z, Berglund B, Sun Q, Nilsson M, et al
    Prevalence of the mcr-1 colistin resistance gene in extended-spectrum beta-lactamase-producing Escherichia coli from human faecal samples collected in 2012 in rural villages in Shandong Province, China.
    Int J Antimicrob Agents. 2017;49:493-497.
    PubMed     Text format     Abstract available


  254. MORALES-BARROSO I, Lopez-Cerero L, Molina J, Bellido M, et al
    Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Int J Antimicrob Agents. 2017;49:498-502.
    PubMed     Text format     Abstract available


    March 2017
  255. SYDENHAM TV, Jensen BH, Petersen AM, Krogfelt KA, et al
    Antimicrobial resistance in the Bacteroides fragilis group in faecal microbiota from healthy Danish children.
    Int J Antimicrob Agents. 2017 Mar 31. pii: S0924-8579(17)30097.
    PubMed     Text format     Abstract available


  256. FLOKAS ME, Karageorgos SA, Detsis M, Alevizakos M, et al
    Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2017 Mar 20. pii: S0924-8579(17)30086.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: